TABLE OF CONTENTS
|  |  |  | Volume 5, March 2016 |  | In this issue Original Articles | |  |  | Original Articles | Top |  | Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cellsB I Bassey-Archibong, J M Kwiecien, S B Milosavljevic, R M Hallett, L G A Rayner, M J Erb, C J Crawford-Brown, K B Stephenson, P-A Bédard, J A Hassell and J M Daniel Oncogenesis 2016 5: e208; 10.1038/oncsis.2016.17 Abstract | Full Text |  |  |  | Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancerP Bouquerel, C Gstalder, D Müller, J Laurent, L Brizuela, R A Sabbadini, B Malavaud, S Pyronnet, Y Martineau, I Ader and O Cuvillier Oncogenesis 2016 5: e209; 10.1038/oncsis.2016.13 Abstract | Full Text |  |  |  | A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumorsY Meng, L Zheng, Y Yang, H Wang, J Dong, C Wang, Y Zhang, X Yu, L Wang, T Xia, D Zhang, Y Guo and B Li Oncogenesis 2016 5: e211; 10.1038/oncsis.2016.25 Abstract | Full Text |  |  |  | A porcine model of osteosarcomaA Saalfrank, K-P Janssen, M Ravon, K Flisikowski, S Eser, K Steiger, T Flisikowska, P Müller-Fliedner, É Schulze, C Brönner, A Gnann, E Kappe, B Böhm, B Schade, U Certa, D Saur, I Esposito, A Kind and A Schnieke Oncogenesis 2016 5: e210; 10.1038/oncsis.2016.19 Abstract | Full Text |  |  |  | Epigenetic suppression of neprilysin regulates breast cancer invasionH M Stephen, R J Khoury, P R Majmudar, T Blaylock, K Hawkins, M S Salama, M D Scott, B Cosminsky, N K Utreja, J Britt and R E Conway Oncogenesis 2016 5: e207; 10.1038/oncsis.2016.16 Abstract | Full Text |  |  |  | Death receptor 6 (DR6) is required for mouse B16 tumor angiogenesis via the NF-κB, P38 MAPK and STAT3 pathwaysX Yang, B Shi, L Li, Z Xu, Y Ge, J Shi, Y Liu and D Zheng Oncogenesis 2016 5: e206; 10.1038/oncsis.2016.9 Abstract | Full Text |  |  |  |  | | Advertisement |  | An online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research.
Part of the Nature Partner Journals series, published in partnership with the Breast Cancer Research Foundation.
Now open for submissions |  | | |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment